Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
3.130
-0.050 (-1.57%)
May 14, 2025, 4:00 PM - Market closed
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.83 million as of May 14, 2025. Its market cap has decreased by -20.41% in one year.
Market Cap
2.83M
Enterprise Value
-776.20K
1-Year Change
-20.41%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $2.83M, a decrease of -96.88%. That is a compound annual growth rate of -53.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 2.88M | -25.28% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.48% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.83M | -28.42% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |